# POGLUT2

## Overview
POGLUT2, or protein O-glucosyltransferase 2, is a gene that encodes an enzyme involved in the post-translational modification of proteins. This enzyme is categorized as a glycosyltransferase and is responsible for the addition of glucose to serine residues within epidermal growth factor-like (EGF) repeats, a process known as O-glucosylation. The protein O-glucosyltransferase 2 is localized in the endoplasmic reticulum, where it plays a crucial role in the proper folding, stability, and secretion of proteins such as fibrillin-1, fibrillin-2, and latent transforming growth factor beta binding protein 1. These proteins are essential components of the extracellular matrix and are involved in various signaling pathways, including the Notch signaling pathway, which is critical for cell differentiation and development (Williamson2021POGLUT2; Takeuchi2018Two). The enzyme's activity is significant for maintaining the structural integrity and function of these proteins, highlighting its importance in both normal cellular processes and disease states (Williamson2021POGLUT2).

## Function
POGLUT2 (protein O-glucosyltransferase 2) is an enzyme that plays a critical role in the post-translational modification of proteins by adding glucose to serine residues within epidermal growth factor-like (EGF) repeats. This modification, known as O-glucosylation, is essential for the proper folding, stability, and secretion of proteins such as fibrillin-1 (FBN1), fibrillin-2 (FBN2), and latent transforming growth factor beta binding protein 1 (LTBP1) (Williamson2021POGLUT2). POGLUT2 is localized in the endoplasmic reticulum, where it assists in protein folding and secretion, contributing to the structural integrity of the extracellular matrix (Williamson2021POGLUT2).

In healthy human cells, POGLUT2 is involved in the modification of over half of the EGF repeats on FBN1, FBN2, and LTBP1, which is crucial for their secretion and function (Williamson2021POGLUT2). The enzyme's activity is linked to β-hydroxylation and calcium binding, which are important for the structural integrity and function of these proteins (Williamson2021POGLUT2). POGLUT2 also plays a role in modulating Notch signaling, a pathway critical for cell differentiation and development, by modifying specific EGF repeats on Notch receptors (Takeuchi2018Two).

## Clinical Significance
Mutations or alterations in the expression of the POGLUT2 gene have been implicated in various diseases and conditions. In the context of cancer, increased levels of POGLUT2 have been observed in multiple cancer types, including breast cancer. This upregulation is associated with gene mutations and amplifications, and it correlates with immune cell infiltration in the tumor microenvironment. Knockdown experiments in breast cancer cell lines have shown that reducing POGLUT2 expression can delay tumor growth and progression, suggesting its role in cancer progression through the Notch signaling pathway (Xu2022A).

In hepatic and pancreatic dysfunction, POGLUT2 expression is linked to the endoplasmic reticulum (ER) stress response. In hepatocytes, upregulation of POGLUT2 is associated with hepatic diseases, as it leads to cell cycle arrest under ER stress conditions. In pancreatic β-cells, high POGLUT2 expression, induced by exposure to palmitate, activates caspase-3-dependent apoptosis, which is a pathway linked to β-cell dysfunction and potentially type 2 diabetes. Inhibiting POGLUT2 in these cells reduces caspase-3 expression and ER stress, indicating its involvement in β-cell apoptosis (Mehboob2021Structure).

These findings highlight the clinical significance of POGLUT2 in various pathological conditions, warranting further research into its potential as a therapeutic target.

## Interactions
POGLUT2 is involved in the post-translational modification of proteins by adding O-glucose to serine residues within epidermal growth factor-like (EGF) repeats. This modification is crucial for the proper folding and secretion of proteins such as fibrillin-1 (FBN1), fibrillin-2 (FBN2), and latent transforming growth factor β-binding protein 1 (LTBP1) (Williamson2021POGLUT2). POGLUT2, along with its homolog POGLUT3, modifies over half of the EGF repeats on these proteins, which are essential components of the extracellular matrix and play a role in TGF-β signaling (Williamson2021POGLUT2).

POGLUT2 also interacts with the Notch signaling pathway by modifying specific EGF repeats on NOTCH1 and NOTCH3. It adds O-glucose to serine 435 on the 11th EGF repeat of NOTCH1, a modification that affects Notch-ligand interactions and influences Notch signaling, which is critical for cell-fate decisions (Takeuchi2018Two). The enzyme requires properly folded EGF repeats for its activity and shows distinct acceptor specificities, indicating a role in the quality control of EGF repeat folding (Takeuchi2018Two). These interactions suggest that POGLUT2 is a key regulator of protein function and signaling pathways through its glycosylation activity.


## References


[1. (Xu2022A) Xianyun Xu, Guangming Xie, Mingfeng Xie, and Qian Liu. A comprehensive role evaluation and mechanism exploration of poglut2 in pan-cancer. Frontiers in Oncology, September 2022. URL: http://dx.doi.org/10.3389/fonc.2022.962540, doi:10.3389/fonc.2022.962540. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.962540)

[2. (Williamson2021POGLUT2) Daniel B. Williamson, Camron J. Sohn, Atsuko Ito, and Robert S. Haltiwanger. Poglut2 and poglut3 o-glucosylate multiple egf repeats in fibrillin-1, -2, and ltbp1 and promote secretion of fibrillin-1. Journal of Biological Chemistry, 297(3):101055, September 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.101055, doi:10.1016/j.jbc.2021.101055. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.101055)

[3. (Takeuchi2018Two) Hideyuki Takeuchi, Michael Schneider, Daniel B. Williamson, Atsuko Ito, Megumi Takeuchi, Penny A. Handford, and Robert S. Haltiwanger. Two novel protein o -glucosyltransferases that modify sites distinct from poglut1 and affect notch trafficking and signaling. Proceedings of the National Academy of Sciences, August 2018. URL: http://dx.doi.org/10.1073/pnas.1804005115, doi:10.1073/pnas.1804005115. This article has 69 citations.](https://doi.org/10.1073/pnas.1804005115)

[4. (Mehboob2021Structure) Muhammad Zubair Mehboob and Minglin Lang. Structure, function, and pathology of protein o-glucosyltransferases. Cell Death &amp; Disease, January 2021. URL: http://dx.doi.org/10.1038/s41419-020-03314-y, doi:10.1038/s41419-020-03314-y. This article has 22 citations.](https://doi.org/10.1038/s41419-020-03314-y)